Opportunity Information: Apply for RFA AG 17 012
Apply for RFA AG 17 012
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866,.
- This funding opportunity was created on May 11, 2016 and posted on May 11, 2016.
- Applicants must submit their applications by Oct 06, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $75,000.00 in funding.
- The number of recipients for this funding is limited to 15 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03) funding opportunity (RFA-AG-17-012) is a discretionary NIH grant program administered by HHS/NIH, with a focus on health research and supported under CFDA 93.866. Its central purpose is career-launch support for early-stage physician-scientists who have been trained in medical or surgical specialties and who want to pivot into aging research or geriatrics. Rather than funding a large, mature research program, GEMSSTAR is designed to help promising clinician-investigators make an early, credible start in the aging/geriatrics research space and position themselves as future leaders in the field.
A defining feature of the opportunity is its emphasis on transdisciplinary research in aging or geriatrics. The intent is to fund smaller, focused projects that can generate high-quality pilot data. That pilot data is meant to serve as a springboard for subsequent, larger aging- or geriatrics-centered grant applications and research programs. In practical terms, this means the funded work should be scoped appropriately for an R03 mechanism, with clear, feasible aims that can be completed within the limited budget and that will produce measurable outputs (for example, preliminary effect estimates, feasibility data, early validation results, initial cohort or registry findings, or proof-of-concept evidence) strong enough to justify the next stage of funding.
Another core theme of the GEMSSTAR FOA is the development environment around the candidate. The National Institute on Aging (NIA) explicitly signals that it cares about whether applicants have the right support to grow into independent aging researchers. This includes the presence of mentorship, access to collaborators across disciplines, institutional commitment, and the overall research infrastructure needed for a physician-scientist to succeed while balancing clinical responsibilities. NIA indicates it will consider the strength of this supportive environment when selecting GEMSSTAR candidates, which effectively makes the training and mentoring context a meaningful part of competitiveness, not just the science alone.
The program uses the NIH R03 small grant mechanism, with an award ceiling of $75,000. The opportunity anticipated making about 15 awards. The original and current closing date listed for this FOA was October 6, 2016, and it was posted May 11, 2016, indicating it was a time-limited solicitation during that period. Even though the date is in the past, the structure and goals described here reflect how NIA framed the program: a targeted on-ramp for early physician-scientists into aging and geriatrics research through manageable, pilot-scale projects.
Eligibility is broad and includes a wide range of domestic organizational types that can host and administer an NIH grant. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and additional entities as clarified in the FOA text. In effect, the organizational eligibility is flexible, but the programmatic intent is tightly focused on supporting early-career physician-scientists in medical or surgical subspecialties who are seeking to transition toward aging research and geriatrics.
In summary, GEMSSTAR (R03) is a small-grant, pilot-data-oriented NIH opportunity from NIA meant to accelerate the transition of early-stage clinician-scientists into aging and geriatrics research. It supports transdisciplinary projects sized for an R03 budget, prioritizes the generation of preliminary data that can unlock future funding, and places real weight on the quality of the mentorship and institutional environment surrounding the applicant as part of the selection process.
Frequently Asked Questions (FAQs)
What is the GEMSSTAR (R03) funding opportunity?
GEMSSTAR stands for Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research. It is an NIH discretionary grant opportunity administered by HHS/NIH, created to help early-stage physician-scientists pivot into aging research or geriatrics through a small, focused R03 project.
Which NIH institute administers this opportunity?
This opportunity is associated with the National Institute on Aging (NIA), which emphasizes both pilot-scale science and the applicant's development environment for launching an aging/geriatrics research trajectory.
What is the central purpose of the program?
The central purpose is career-launch support for early-stage clinician-investigators trained in medical or surgical specialties who want to transition into aging research or geriatrics, using a manageable project to establish credibility and momentum in the field.
Is this meant to fund a large, mature research program?
No. The program is designed to fund smaller, focused projects suitable for the NIH R03 mechanism. The intent is to generate strong pilot data rather than support a large, established research program.
What kind of research does GEMSSTAR prioritize?
The opportunity emphasizes transdisciplinary research in aging or geriatrics. Projects should be tightly scoped and structured to produce high-quality preliminary findings that can support future aging- or geriatrics-centered grant applications.
What does "transdisciplinary" mean in the context of this FOA?
Based on the FOA description, transdisciplinary work is framed as research supported by access to collaborators across disciplines and a broader team/scientific environment that helps a clinician-investigator enter aging/geriatrics research with the right expertise and support.
What is the grant mechanism used for GEMSSTAR?
The program uses the NIH R03 small grant mechanism, which is typically used for concise, limited-scope projects intended to produce discrete outputs such as pilot data.
What is the maximum award amount?
The award ceiling described for this FOA is $75,000.
How many awards were anticipated?
The opportunity anticipated making about 15 awards.
What types of results should the project produce?
The FOA emphasizes measurable pilot outputs that can serve as a springboard for future funding. Examples provided include preliminary effect estimates, feasibility data, early validation results, initial cohort or registry findings, and proof-of-concept evidence.
How should applicants think about project scope for this opportunity?
The project should be scoped appropriately for an R03 budget and structure, with clear and feasible aims that can be completed within the limited budget while still producing meaningful preliminary results for the next stage of funding.
How important is mentorship and the candidate's development environment?
The FOA description makes mentorship and the surrounding development environment a major competitiveness factor. NIA indicates it will consider the strength of the support system when selecting candidates, not just the research idea alone.
What elements of the development environment are highlighted as important?
The FOA highlights mentorship, access to collaborators across disciplines, institutional commitment, and the research infrastructure needed for a physician-scientist to grow while balancing clinical responsibilities.
Who is the opportunity designed to support?
It is designed for early-stage physician-scientists who have been trained in medical or surgical specialties and are seeking to transition into aging research or geriatrics.
What is the opportunity's CFDA number and focus area?
The opportunity is supported under CFDA 93.866 and is described as focusing on health research, specifically positioned as an on-ramp into aging research and geriatrics.
What is the FOA identifier for this opportunity?
The FOA is identified as RFA-AG-17-012, and it is described as the GEMSSTAR (R03) funding opportunity.
When was this FOA posted and what was the closing date?
It was posted May 11, 2016, and the listed closing date was October 6, 2016. The description indicates it was a time-limited solicitation during that period.
Is the closing date in the past?
Yes. The information provided states that the original and current closing date listed was October 6, 2016.
Does organizational eligibility appear broad or narrow?
Organizational eligibility is described as broad and flexible across many domestic entity types, while the program's intent is tightly focused on supporting early-career physician-scientists transitioning into aging/geriatrics research.
What types of organizations are eligible to apply (as host/applicant organizations)?
Eligible applicant organization types listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses, along with additional entities as clarified in the FOA text.
What is the program trying to help awardees do next?
The program is designed so that pilot data generated from the R03 can support subsequent, larger aging- or geriatrics-centered grant applications and help build a longer-term research program led by the clinician-investigator.
What makes a GEMSSTAR application competitive based on this description?
Competitiveness is framed around (1) a feasible, R03-sized project that produces credible pilot data in aging/geriatrics, and (2) a strong development environment, including mentorship, collaborators, institutional commitment, and infrastructure supporting a physician-scientist balancing clinical work.
Browse more opportunities from the same category: Health
Next opportunity: Information and Education Outreach support for GNLCC
Previous opportunity: 2016 Work Zone and Guardrail Safety Training Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 17 012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 17 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| From Association to Function in the Alzheimers Disease Post Genomics Era (R01) Apply for RFA AG 17 010 Funding Number: RFA AG 17 010 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK15 150302CONT16 Funding Number: CDC RFA CK15 150302CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Learning Collaboratives for Advanced Business Acumen Skills Apply for HHS 2016 ACL CIP PPBA 0181 Funding Number: HHS 2016 ACL CIP PPBA 0181 Agency: HHS-ACL Category: Health Funding Amount: $500,000 |
| Creutzfeldt - Jakob Disease (CJD) Support, Education, and Awareness Projects as Apply for CDC RFA CK15 150402CONT16 Funding Number: CDC RFA CK15 150402CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Environmental Sampling with NAU for High Consequence Pathogens Apply for CDC RFA CK16 1606 Funding Number: CDC RFA CK16 1606 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: $300,000 |
| Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 17 006 Funding Number: HRSA 17 006 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Jurisdictional Approach to Curing Hepatitis C Among HIV/HCV Coinfected People of Color - Evaluation and Technical Assistance Center Apply for HRSA 16 188 Funding Number: HRSA 16 188 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp) Apply for PA 16 259 Funding Number: PA 16 259 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites Apply for HRSA 16 189 Funding Number: HRSA 16 189 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 16 265 Funding Number: PAR 16 265 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 16 264 Funding Number: PAR 16 264 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) Apply for PAR 16 262 Funding Number: PAR 16 262 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 1603 Funding Number: CDC RFA IP16 1603 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $400,000 |
| NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 16 267 Funding Number: PAR 16 267 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization Apply for CDC RFA IP16 1606 Funding Number: CDC RFA IP16 1606 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $2,000,000 |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP16 1604 Funding Number: CDC RFA IP16 1604 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $250,000 |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 16 269 Funding Number: PAR 16 269 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) Apply for RFA AI 16 047 Funding Number: RFA AI 16 047 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) Apply for PAR 16 268 Funding Number: PAR 16 268 Agency: HHS-NIH11 Category: Health Funding Amount: $50,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 16 270 Funding Number: PAR 16 270 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 17 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.